ONO PHARMACEUTICAL CO
- Country
- π―π΅Japan
- Ownership
- -
- Established
- 1947-01-01
- Employees
- -
- Market Cap
- $7.1B
- Website
- https://www.ono.co.jp/
MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 Diabetes
- Conditions
- Interventions
- First Posted Date
- 2012-01-25
- Last Posted Date
- 2013-07-09
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Registration Number
- NCT01517321
- Locations
- π―π΅
Tohoku Region Clinical Site, Tohoku, Japan
π―π΅Kinki Region Clinical Site, Kinki, Japan
π―π΅Chubu Region Clinical Site, Chubu, Japan
A Study to Investigate the Effects of Food and Morning Versus Evening on Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women
- First Posted Date
- 2011-06-28
- Last Posted Date
- 2013-01-18
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 25
- Registration Number
- NCT01384188
- Locations
- π¬π§
London Clinical Site, London, United Kingdom
π¬π§Guildford Clinical Site, Guildford, Surrey, United Kingdom
A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers
- First Posted Date
- 2011-06-23
- Last Posted Date
- 2012-06-13
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 15
- Registration Number
- NCT01379586
- Locations
- π¬π§
Leeds Clinical Site, Leeds, West Yorkshire, United Kingdom
ONO-7746 Study in Healthy Adult Subject
- First Posted Date
- 2010-04-20
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 72
- Registration Number
- NCT01106664
- Locations
- πΊπΈ
Austin Clinical Site, Austin, Texas, United States
ONO-7746 Study in Healthy Adult Subjects
- First Posted Date
- 2009-08-11
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 48
- Registration Number
- NCT00956371
- Locations
- πΊπΈ
Austin, Austin, Texas, United States
Study of ONO-1101 in Patients Scheduled for Multi-Slice Computed Tomography (CT)
- First Posted Date
- 2009-06-19
- Last Posted Date
- 2012-06-13
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 258
- Registration Number
- NCT00924586
- Locations
- π―π΅
Kanto Region, Kanto, Japan
π―π΅Kyushu Region, Kyushu, Japan
Study of ONO-8539 in Patients With Overactive Bladder
- Conditions
- Interventions
- First Posted Date
- 2009-04-06
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 435
- Registration Number
- NCT00876421
MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes Mellitus
- First Posted Date
- 2009-03-02
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 266
- Registration Number
- NCT00854035
- Locations
- π―π΅
Kinki Region, Kinki, Japan
π―π΅Hokuriku Region, Hokuriku, Japan
π―π΅Kyushu Region, Kyushu, Japan
ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 17
- Registration Number
- NCT00836888
A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)
- First Posted Date
- 2008-06-11
- Last Posted Date
- 2012-06-13
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 15
- Registration Number
- NCT00694941
- Locations
- π¬π§
Prof. Nigel Leigh, Academic Neuroscience Centre, London, United Kingdom
π³π±Prof Marianne de Visser, Academic Medical Centre (AMC) Amsterdam - Dept of Neurology, Amsterdam, Netherlands
π¬π§Dr. Chris McDermott, Royal Hallamshire Hospital, Sheffield, United Kingdom